Neem

<h3> Absolute Contraindications of Neem </h3> <h4>Pregnancy (may cause miscarriage / harm to developing pregnancy)</h4> <ul> <li> 🤰 <li> Recommendation: Do not take neem internally during pregnancy; avoid concentrated neem seed extracts and oils while trying to conceive or during gestation. <li> Reasoning: Animal studies and primate experiments show certain purified neem seed/seed-extract preparations can terminate early pregnancies and cause changes in pregnancy hormones and immune signals; mechanisms include immunomodulation and progesterone reduction observed experimentally. <li> Scientific_Study_Title: Induced termination of pregnancy by purified extracts of Azadirachta Indica (Neem): mechanisms involved <li> Scientific_Study_Authors: G P Talwar, S Shah, S Mukherjee, R Chabra <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/9228306/ <li> Scientific_Study_Excerpt: <p>Talwar et al. report that purified neem seed extracts produced complete resorption/termination of early pregnancy in rodents and primates when given orally during early implantation. The investigators measured declines in progesterone and rises in cellular immune mediators (TNF-alpha, interferon-gamma) and a transient increase in CD4/CD8 lymphocytes in lymphoid tissues after treatment. The study shows a cascade of immunomodulatory and endocrine changes that culminated in early pregnancy loss in experimental animals, and the authors conclude that neem seed immunomodulators are capable of abrogating early pregnancy when given systemically.</p> </ul> <h4>Infants / Young children - ingestion (risk of toxic encephalopathy, metabolic acidosis, seizures)</h4> <ul> <li> 🧒⚠️ <li> Recommendation: Never give neem oil or concentrated seed extracts to infants or young children orally or nasally; keep neem oils away from children’s reach. <li> Reasoning: Case reports and series document severe toxic encephalopathy, recurrent seizures and metabolic acidosis in infants after accidental oral or nasal administration of neem oil; even small volumes have caused life-threatening outcomes. <li> Scientific_Study_Title: Margosa oil poisoning as a cause of toxic encephalopathy <li> Scientific_Study_Authors: S M Lai, K W Lim, H K Cheng <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/2259944/ <li> Scientific_Study_Excerpt: <p>Case reports summarized by Lai et al. describe neonates and infants who developed vomiting, drowsiness, tachypnea, metabolic acidosis and recurrent generalized seizures following ingestion of marginal quantities of margosa (neem) oil. Laboratory findings often showed leucocytosis and significant metabolic acidosis; clinical management was supportive with seizure control and correction of acid-base disturbances. While many patients recover with supportive care, fatalities and long-term neurological deficits have been reported, which supports a firm contraindication to internal use of neem oil in infants.</p> </ul> <h4>Severe pre-existing liver disease (risk of hepatotoxicity / Reye-like syndrome)</h4> <ul> <li> 🟠🍃 <li> Recommendation: Avoid concentrated neem oil or unstandardized high-dose neem extracts in people with known severe liver impairment or recent unexplained hepatic dysfunction; consult a hepatologist before any internal neem use. <li> Reasoning: Reports associate margosa/neem oil ingestion with acute hepatic injury, metabolic disturbances resembling Reye’s-type illness and mitochondrial dysfunction; damaged liver function increases vulnerability to further injury from xenobiotics. <li> Scientific_Study_Title: Margosa Oil (LiverTox review) <li> Scientific_Study_Authors: LiverTox (NCBI / NIDDK summary authors; review entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31643748/ <li> Scientific_Study_Excerpt: <p>The LiverTox review collates case reports and toxicology data showing that margosa (neem) oil ingestion has been linked to acute onset metabolic acidosis, progressive hepatic encephalopathy and multi-organ failure in some patients. The review highlights mitochondrial dysfunction and inhibition of oxidative phosphorylation as plausible mechanisms and notes that outbreaks of severe toxicity have occurred where contaminated or incorrectly prepared oils were used. The authors advise caution and report that clinical management is supportive; the product has been implicated as a probable, though rare, cause of clinically apparent liver injury.</p> </ul> <h4>Known hypersensitivity or previous serious dermatologic reaction to neem (topical leukoderma or allergic dermatitis)</h4> <ul> <li> 🚫🧴 <li> Recommendation: Do not use topical neem (oils/creams) if you have a known neem allergy or prior depigmenting reaction to neem; prefer patch testing and avoid use over large skin areas if sensitivity is unknown. <li> Reasoning: Several neem limonoids inhibit melanogenesis in cell and animal models and case reports / dermatology literature link topical neem exposure to contact dermatitis and, rarely, chemical leukoderma or hypopigmentation; sensitive individuals can develop persistent pigment changes. <li> Scientific_Study_Title: Molecular Mechanisms of Anti-Melanogenic Gedunin Derived from Neem Tree (Azadirachta indica) <li> Scientific_Study_Authors: Hwang-Ju Jeon, Kyeongnam Kim, Chaeeun Kim, Myoung-Jin Kim, Tae-Oh Kim, et al. <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914499/ <li> Scientific_Study_Excerpt: <p>Jeon et al. studied gedunin, a neem limonoid, and showed it reduces melanin production in cultured melanoma cells and zebrafish embryos by inhibiting tyrosinase activity and lowering protein levels of MITF and related melanogenic enzymes. These mechanistic findings explain how neem compounds can reduce pigmentation and support clinical reports of localized depigmentation or leukoderma after topical exposure in susceptible people. The paper underlines that specific neem constituents directly inhibit the cellular machinery that makes melanin.</p> </ul> <h3> Relative Contraindications of Neem </h3> <h4>Concomitant use with antidiabetic medication (risk of additive hypoglycemia)</h4> <ul> <li> 🩸📉 <li> Recommendation: If you already use antidiabetic drugs (insulin, sulfonylureas, metformin, etc.), consult your clinician before starting internal neem extracts; blood glucose should be closely monitored and medication adjusted if needed. <li> Reasoning: Clinical trials show standardized neem extracts lower fasting and postprandial glucose and improve insulin resistance; when combined with other glucose-lowering medicines the cumulative effect may cause hypoglycemia unless doses are adjusted. <li> Scientific_Study_Title: Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control... (Randomized, Double-Blind, Placebo-Controlled Clinical Study) <li> Scientific_Study_Authors: R. S. (authors as listed on PubMed entry for the trial) - (see linked PubMed record) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33244247/ <li> Scientific_Study_Excerpt: <p>This randomized, double-blind, placebo-controlled clinical trial enrolled type 2 diabetes patients already on metformin and demonstrated that adding standardized aqueous neem extract reduced fasting and postprandial glucose, HbA1c and markers of insulin resistance over 12 weeks compared with placebo. The trial reported glucose reductions that were clinically significant at multiple doses, showing that neem has additive glycemic effects on top of standard therapy-supporting the need for monitoring and possible dose adjustment when combined with hypoglycemic drugs.</p> </ul> <h4>Concurrent use with immunosuppressant therapy (theoretical reduced efficacy of immunosuppression)</h4> <ul> <li> 🧪⚖️ <li> Recommendation: If you are on immunosuppressive drugs (e.g., post-transplant or autoimmune therapy), avoid internal neem extracts unless under specialist supervision; discuss risks with your treating physician. <li> Reasoning: Animal studies show neem oil can stimulate cell-mediated immunity (increased macrophage activity, interferon-gamma production and T-cell proliferation). This immunostimulatory action could theoretically counteract immunosuppressive medications or complicate immune control. <li> Scientific_Study_Title: Immunomodulatory effects of neem (Azadirachta indica) oil <li> Scientific_Study_Authors: S N Upadhyay, S Dhawan, S Garg, G P Talwar <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/1452404/ <li> Scientific_Study_Excerpt: <p>Upadhyay et al. administered neem oil intraperitoneally in mice and observed enhanced peritoneal leukocyte counts, increased macrophage phagocytic function, higher MHC class II expression and induction of interferon-gamma. Splenic lymphocytes showed greater proliferative responses to mitogens and antigenic challenges. The authors concluded that neem oil acts as a non-specific immunostimulant with selective activation of cell-mediated immune mechanisms-supporting a caution for people whose therapeutic goals require immune suppression.</p> </ul> <h4>Concurrent use with drugs highly metabolized by cytochrome P450 (possible metabolic interactions)</h4> <ul> <li> ⚗️🔁 <li> Recommendation: If you take narrow-therapeutic-index drugs metabolized by major CYP enzymes (e.g., CYP3A4, CYP1A2), discuss with a clinician or pharmacist before using high-dose neem extracts; monitoring drug levels or clinical effects may be required. <li> Reasoning: In silico and experimental analyses indicate some neem bioactives (quercetin, nimbolide and others) can inhibit CYP enzymes (CYP1A2 and CYP3A4) and modulate CYP expression, which could alter the metabolism and blood levels of co-administered drugs. <li> Scientific_Study_Title: Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 (ADMET/CYP findings) <li> Scientific_Study_Authors: Felix Oluwasegun Ishabiyi, James Okwudirichukwu Ogidi, Baliqis Adejoke Olukade, et al. <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473084/ <li> Scientific_Study_Excerpt: <p>This computational ADMET study evaluated multiple neem bioactives for pharmacokinetic properties and predicted that several compounds (e.g., quercetin, nimbolide) can inhibit key CYP enzymes including CYP1A2 and CYP3A4 and may influence P-glycoprotein. The authors caution that such inhibitory potential could change systemic exposure of co-administered drugs metabolized by these enzymes and therefore pose a risk of drug-drug interactions; they recommend further in vitro/in vivo work but advise clinical caution when neem is combined with CYP-substrate medications.</p> </ul>